613 studies found for:    amyloid
Show Display Options
Rank Status Study
1 Recruiting Escitalopram Effects on CSF Amyloid Beta
Condition: Amyloid Beta Protein
Intervention: Drug: Escitalopram or Placebo
2 Withdrawn F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)
Condition: Cerebral Amyloid Angiopathy
3 Completed Serum Amyloid A Protein And Fetuin A Levels
Condition: Periodontal Diseases
Interventions: Biological: Fetuin-A;   Biological: Serum Amyloid A
4 Recruiting Amyloïd Load in Elderly Population: Effect of Cognitive Reserve
Conditions: Plaque, Amyloid;   Cognitive Deficits
Interventions: Other: PET;   Other: MRI;   Other: neuropsychological tests
5 Recruiting Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy
Conditions: Intracerebral Hemorrhage;   Cerebral Amyloid Angiopathy;   Ischemic Stroke
6 Completed
Has Results
Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
Conditions: Down Syndrome;   Amyloid Beta-protein
Intervention: Drug: Florbetaben (BAY94-9172)
7 Completed How Beta-amyloid Imagining Influences Clinician Diagnosis and Management of Hypothetical Patients With Cognitive Complaints
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment
Intervention: Device: Beta amyloid imaging
8 Recruiting Efficacy and Safety of ISIS-TTR Rx in Familial Amyloid Polyneuropathy
Conditions: FAP;   Familial Amyloid Polyneuropathy;   TTR;   Transthyretin;   Amyloidosis
Interventions: Drug: ISIS-TTR Rx;   Drug: Placebo
9 Enrolling by invitation Open-Label Extension Assessing Long Term Safety and Efficacy of ISIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)
Conditions: FAP;   Familial Amyloid Polyneuropathy;   TTR;   Transthyretin;   Amyloidosis
Intervention: Drug: ISIS-TTR Rx
10 Enrolling by invitation CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
Condition: Alzheimer's Disease
11 Enrolling by invitation Amyloid Accumulation After Mild Traumatic Brain Injury
Condition: Traumatic Brain Injury
Intervention: Drug: [18F]AV-45 PET amyloid binding imaging
12 Completed
Has Results
Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients
Condition: Parkinson's Disease
Intervention: Drug: florbetapir F 18
13 Completed
Has Results
Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain
Condition: Alzheimer's Disease
Intervention: Drug: florbetapir F 18
14 Completed
Has Results
PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
Condition: Normal Pressure Hydrocephalus
Intervention: Drug: [18F] Flutemetamol
15 Completed
Has Results
An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy
Conditions: Familial Amyloid Polyneuropathy;   ATTR-PN
Intervention: Drug: Fx-1006A
16 Completed
Has Results
Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects
Condition: Healthy
Intervention: Drug: [18F] Flutemetamol
17 Unknown  History of Amyloid Deposition in Adults With Down Syndrome
Conditions: Down Syndrome;   Amyloid Deposition;   Alzheimers Disease
18 Completed
Has Results
Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology
Condition: Alzheimer Disease
Intervention: Drug: Florbetaben (BAY94-9172)
19 Active, not recruiting Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy
Condition: Cerebral Amyloid Angiopathy
Interventions: Biological: Ponezumab;   Other: placebo
20 Not yet recruiting Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
Condition: Mild Cognitive Impairment
Interventions: Procedure: Amyloid imaging;   Procedure: FDG-PET

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years